AMPH:NASDAQ
Amphastar Pharmaceuticals, Inc
$25.37
arrow_downward
-0.24%(-0.060) 1D
$25.30
arrow_downward
-0.28% (-0.070)todayPre-market
Closed: Oct 5, 4:00:02 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMPH...
Open
$25.43
High
$25.70
Low
$25.17
Mkt. cap
1.08B
Avg. vol.
483.93K
Volume
429.00
P/E ratio
14.84
52-wk high
$29.52
52-wk low
$16.64
EPS
$1.71
Beta
0.90
Shares outstanding
42.54M
No. of employees
2K
Open
$25.43
High
$25.70
Low
$25.17
Mkt. cap
1.08B
Avg. vol.
483.93K
Volume
429.00
P/E ratio
14.84
52-wk high
$29.52
52-wk low
$16.64
EPS
$1.71
Beta
0.90
Shares outstanding
42.54M
No. of employees
2K
News stories
From web sources and news partners
Simply Wall Street
·
12 minutes ago
Will Mood And Mind Drinks Change Walmart's (WMT) Narrative
Enidnews.com
·
1 hour ago
Everli, a Leading Italian E-Grocery Marketplace, Advances Toward Nasdaq Listing as SEC Declares Registration Statement Effective
CryptoRank
·
50 minutes ago
AGM Group raises $11M in private placement to bolster Nasdaq-listed balance sheet
Reuters
·
36 minutes ago
Wall Street profits soar to $45.9 billion in first half of 2026, report shows
Profile
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around $20 to $40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally.
In March 2018, the company won a patent infringement lawsuit brought against it by Momenta Pharmaceuticals and Sandoz Inc in an ongoing antitrust case.
In April 2023, Amphastar Pharmaceuticals bought Baqsimi from Eli Lilly in a deal worth over $1bn. Wikipedia
About Amphastar Pharmaceuticals, Inc
CEO-
Employees1.98K
Founded1996
HeadquartersRancho Cucamonga, California, United States
SectorPharmaceutical industry
Websiteamphastar.com